Scholars Central

Conference abstractPublished 12 Mar 2018

Fish oil as chemosensitizer: Targeting onset of drug resistance in colon cancer cells

Authors: Isha Rani, Bhoomika Sharma, Satinder Kaur, Sandeep Mahiwal, Navneet Agnihotri

Panjab University, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Antineoplastic resistance continues to be a major impediment in medical oncology. The current strategies have been mainly focused on use of chemosensitizers to combat cancer resistance. Our previous studies demonstrated that fish oil (FO) rich in n-3 PUFAs act as a potential chemosensitizer against colon cancer cells. The mechanistic hypothesis may be effective strategy of fish oil as chemosensitizer in abrogating/delaying onset of drug resistance. Therefore, the present study is designed to understand the role of fish oil as an adjuvant to circumvent the mechanisms of drug resistance in experimental colon carcinoma. The colon cancer was induced by 1,2- dimethylhydrazine (DMH)/dextran sulfate sodium (DSS) and further animals were treated with 5-FU, FO and 5-FU+FO regimens. The principle mechanisms which promote/enable drug resistance were delineated by analyzing variations in the expression of drug transporters and membrane characteristics, drug and its metabolites distribution at target sites and cancer stem cells expression using various methods. We observed that nutritional intervention of fish oil along with 5-FU decreased the expression of drug efflux transporters (ABCB1, ABCC5) and increased the cellular uptake of drug and its metabolites at target site. In addition, synergism of 5-FU and FO decreased the expression of cancer stem cells which are generally spared by chemotherapeutic treatment due to drug resistance. The combinatorial regimens also overcome drug resistance by modulating biophysical properties of membrane and altering membrane composition. The use of fish oil as chemosensitizer with an acceptable safety profile may be an appropriate strategy to improve clinical potential in cancer resistant therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Isha Rani”
  • BylineArticles whose byline prints “Bhoomika Sharma”
  • BylineArticles whose byline prints “Satinder Kaur”
  • BylineArticles whose byline prints “Sandeep Mahiwal”
  • BylineArticles whose byline prints “Navneet Agnihotri”